Aminophylline Prophylaxis For Postdural Puncture Headache

Sponsor
Diskapi Yildirim Beyazit Education and Research Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT02150304
Collaborator
(none)
100
1
5
20.2

Study Details

Study Description

Brief Summary

postdural puncture headache is a rare but serious complication of spinal anesthesia. many drugs were studied in prevention or treatment of that complication. However, there are limited numbers of trials about intravenous aminophylline for prevention. because of that we retrospectively aimed to investigate the effectiveness of aminophylline for postdural puncture headache in cesarean section.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    retrospective trial about the effect of intravenous aminophylline for prevention of PDPH after caserean section with spinal anesthesia

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    100 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Retrospective
    Official Title:
    Phase IV Study of Intravenous Aminophylline During Spinal Anesthesia
    Study Start Date :
    Jan 1, 2014
    Actual Primary Completion Date :
    Jun 1, 2014
    Actual Study Completion Date :
    Jun 1, 2014

    Arms and Interventions

    Arm Intervention/Treatment
    intravenous aminophylline

    intravenous aminophylline use during spinal anesthesia

    no intravenous aminophylline

    no use of intravenous aminophylline during spinal anesthesia

    Outcome Measures

    Primary Outcome Measures

    1. postdural puncture headache [postoperative 2 weeks]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 45 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • patients aolder than 18 years old
    Exclusion Criteria:
    • conversion to general anesthesia

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Dışkapı Yıldırım Beyazıt Education and Research Hospital Ankara Turkey 06110

    Sponsors and Collaborators

    • Diskapi Yildirim Beyazit Education and Research Hospital

    Investigators

    • Principal Investigator: ibrahim öztürk, M.D., dışkapı yıldırım beyazıt education and research hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    İBRAHİM ÖZTÜRK, doctor, Diskapi Yildirim Beyazit Education and Research Hospital
    ClinicalTrials.gov Identifier:
    NCT02150304
    Other Study ID Numbers:
    • PDPHAMINOPHYLLINE
    First Posted:
    May 29, 2014
    Last Update Posted:
    Aug 5, 2015
    Last Verified:
    Aug 1, 2015
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 5, 2015